A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors-Reference-Cited by-同舟云学术

A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors

Published:2008-12-13 Issue:6 Volume:63 Page:1147-1156
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Schelman William R.,Morgan-Meadows Sherry,Marnocha Rebecca,Lee Fred,Eickhoff Jens,Huang Wei,Pomplun Marcia,Jiang Zhisheng,Alberti Dona,Kolesar Jill M.,Ivy Percy,Wilding George,Traynor Anne M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-008-0890-8.pdf

Reference33 articles.

1. Cory JG, Cory AH, Rappa G, Lorico A, Liu MC, Lin TS, Sartorelli AC (1994) Inhibitors of ribonucleotide reductase. Comparative effects of amino- and hydroxy-substituted pyridine-2-carboxaldehyde thiosemicarbazones. Biochem Pharmacol 48:335–344

2. Alvero AB, Chen W, Sartorelli AC, Schwartz P, Rutherford T, Mor G (2006) Triapine (3-amino-2-carboxaldehyde thiosemicarbazone) Induces Apoptosis in Ovarian Cancer Cells. J Soc Gynecol Investig 13(2):145–152

3. Elford HL, Freese M, Passamani E, Morris HP (1970) Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chem 245:5228–5233

4. Yu Y, Wong J, Lovejoy DB, Kalinowshi DS, Richardson DR (2006) Chelators at the cancer coalface: desferrioxamine to Triapine and beyond. Clin Cancer Res 12(23):6876–6883

5. Nordlund P, Sjoberg B-M, Eklund H (1990) Three-dimensional structure of the free radical protein of ribonucleotide reductase. Nature 345:593–598

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Ribonucleotide Reductase Induces Endoplasmic Reticulum Stress and Apoptosis, Leading to the Death of Docetaxel-resistant Prostate Cancer Cells;Anti-Cancer Agents in Medicinal Chemistry;2023-10

2. Antiproliferative Activity and DNA Interaction Studies of a Series of N4,N4-Dimethylated Thiosemicarbazone Derivatives;Molecules;2023-03-20

3. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present;Biomolecules;2022-06-10

4. Harnessing microbial iron chelators to develop innovative therapeutic agents;Journal of Advanced Research;2021-11

5. Modulation of Intracellular Copper Levels as the Mechanism of Action of Anticancer Copper Complexes: Clinical Relevance;Biomedicines;2021-07-21